A carregar...
Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study
PURPOSE: The mammalian target of rapamycin (mTOR) is activated in Kaposi sarcoma (KS) and its inhibitor, rapamycin, has induced KS regression in transplant-associated KS. This study aimed to evaluate rapamycin's safety and toxicity in HIV-infected individuals with KS receiving antiretroviral th...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3302934/ https://ncbi.nlm.nih.gov/pubmed/22067664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31823e7884 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|